Lummis Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.09M Buy
2,675
+1
+0% +$1.02K 1.85% 17
2026
Q1
$2.5M Hold
2,674
1.49% 22
2025
Q4
$2.87M Hold
2,674
1.77% 18
2025
Q3
$2.04M Hold
2,674
1.34% 23
2025
Q2
$1.67M Hold
2,674
1.1% 26
2025
Q1
$2.4M Buy
2,674
+2,668
+44,467% +$2.22M 1.67% 21
2024
Q4
$4.63K Hold
6
0.01% 108
2024
Q3
$5.32K Hold
6
0.01% 109
2024
Q2
$5.43K Hold
6
0.01% 107
2024
Q1
$4.67K Sell
6
-2,668
-100% -$1.9M 0.01% 116
2023
Q4
$1.56M Buy
+2,674
New +$1.56M 1.19% 25

Other funds holding LLY

Lummis Asset Management's LLY Position: Q2 2026 in Review

Lummis Asset Management increased its Eli Lilly (LLY) stake by 0.04% in Q2 2026, buying an estimated $1.02K and bringing the position to 2,675 shares worth $3.09M. The position accounts for 1.85% of the portfolio, ranked #17.

Lummis Asset Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lummis Asset Management held 2,675 shares of Eli Lilly worth $3.09M as of Q2 2026.
  • Lummis Asset Management bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 1.85% of Lummis Asset Management's portfolio in Q2 2026, its #17 holding.
  • Lummis Asset Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lummis Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.